World's Best Scientists 2026 revealed!
Nina Tolkoff-Rubin

Nina Tolkoff-Rubin

D-Index & Metrics

Medicine

D-Index
72
Citations
20539
World Ranking
19808
National Ranking
9865

Nina Tolkoff-Rubin publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Nina Tolkoff-Rubin sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 221 publications — 4th percentile

4% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Nina Tolkoff-Rubin D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Nina Tolkoff-Rubin sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 72 D-Index — 2nd percentile

2% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Nina Tolkoff-Rubin is affiliated with Harvard University in the United States and focuses their research primarily within the field of Medicine. Their scholarly output encompasses several subfields including Nephrology, Oncology, Transplantation, Infectious Diseases, and Neurology.

Their work has concentrated on topics such as Renal Diseases and Glomerulopathies, COVID-19 Clinical Research Studies, Long-Term Effects of COVID-19, COVID-19 and healthcare impacts, Renal Transplantation Outcomes and Treatments, Organ and Tissue Transplantation Research, and Transplantation: Methods and Outcomes.

Frequent co-authors collaborating with Nina Tolkoff-Rubin include Andrew S. Allegretti, Ivy A. Rosales, Scott Krinsky, Paul Endres, and Russel J. Roberts. This network reflects a multidisciplinary approach involving nephrology, transplantation, and infectious disease studies.

Their publications have appeared in a range of specialized clinical and research journals. Regular venues for their research include:

  • Journal of the American Society of Nephrology
  • Kidney360
  • Journal of Thrombosis and Thrombolysis
  • American Journal of Nephrology
  • Transplantation Proceedings

Significant recent papers authored or co-authored by Nina Tolkoff-Rubin are:

  • "Banff Human Organ Transplant Transcripts Correlate with Renal Allograft Pathology and Outcome: Importance of Capillaritis and Subpathologic Rejection" (2022), Journal of the American Society of Nephrology
  • "The Gut and Blood Microbiome in IgA Nephropathy and Healthy Controls" (2021), Kidney360
  • "Filter clotting with continuous renal replacement therapy in COVID-19" (2020), Journal of Thrombosis and Thrombolysis
  • "Accelerated Venovenous Hemofiltration as a Transitional Renal Replacement Therapy in the Intensive Care Unit" (2020), American Journal of Nephrology
  • "Resolution of a High Grade and Metastatic BK Polyomavirus-Associated Urothelial Cell Carcinoma Following Radical Allograft Nephroureterectomy and Immune Checkpoint Treatment: A Case Report" (2020), Transplantation Proceedings

Best Publications

  • HLA-Mismatched Renal Transplantation without Maintenance Immunosuppression

    Tatsuo Kawai;A. Benedict Cosimi;Thomas Richard Spitzer;Nina Ellen Tolkoff-Rubin

  • Strategies to improve long-term outcomes after renal transplantation.

    Manuel Pascual;Tom Theruvath;Tatsuo Kawai;Nina Tolkoff-Rubin

  • Complement activation in acute humoral renal allograft rejection: diagnostic significance of C4d deposits in peritubular capillaries.

    A B Collins;E E Schneeberger;M A Pascual;S L Saidman

  • Acute Humoral Rejection in Kidney Transplantation: II. Morphology, Immunopathology, and Pathologic Classification

    Shamila Mauiyyedi;Marta Crespo;A Bernard Collins;Eveline E Schneeberger

  • Chronic Humoral Rejection: Identification of Antibody-Mediated Chronic Renal Allograft Rejection by C4d Deposits in Peritubular Capillaries

    Shamila Mauiyyedi;Patricia Della Pelle;Susan Saidman;A Bernard Collins

  • Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: the induction of allograft tolerance through mixed lymphohematopoietic chimerism.

    T R Spitzer;F Delmonico;N Tolkoff-Rubin;S McAfee

  • Acute humoral rejection in renal allograft recipients: I. Incidence, serology and clinical characteristics.

    Marta Crespo;Manuel Pascual;Nina Tolkoff-Rubin;Shamila Mauiyyedi

  • TREATMENT OF ACUTE RENAL ALLOGRAFT REJECTION WITH OKT3 MONOCLONAL ANTIBODY

    A. Cosimi;Robert Burton;Robert Colvin;Gideon Goldstein

  • Infection in the renal transplant recipient

    Robert H. Rubin;John S. Wolfson;A.Benedict Cosimi;Nina E. Tolkoff-Rubin

  • A phase I trial of immunosuppression with anti-ICAM-1 (CD54) mAb in renal allograft recipients.

    Craig Haug;Robert Colvin;Francis DELMONIco;Hugh Auchincloss

  • Controlled clinical trial of prophylactic human-leukocyte interferon in renal transplantation. Effects on cytomegalovirus and herpes simplex virus infections.

    Cheeseman Sh;Rubin Rh;Stewart Ja;Tolkoff-Rubin Ne

  • Glomerulopathy Associated With Cytomegalovirus Viremia in Renal Allografts

    W.P. Richardson;R.B. Colvin;S.H. Cheeseman;N.E. Tolkoff-Rubin

  • Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in vivo and in vitro analyses.

    Y. Fudaba;T. R. Spitzer;J. Shaffer;T. Kawai

  • Prevalence of renal cell carcinoma in patients with ESRD pre-transplantation: A pathologic analysis

    Mark D. Denton;Colm C. Magee;Cyril Ovuworie;Shamila Mauiyyedi

  • Posttransplant diabetes mellitus in liver transplant recipients: risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality.

    S Baid;A B Cosimi;M L Farrell;D A Schoenfeld

  • Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease.

    Bühler Lh;Spitzer Tr;Sykes M;Sachs Dh

  • Efficacy of single-dose and conventional amoxicillin therapy in urinary-tract infection localized by the antibody-coated bacteria technic.

    Leslie S. T. Fang;Nina E. Tolkoff-Rubin;Robert H. Rubin

  • Symptomatic cytomegalovirus disease in the cytomegalovirus antibody seropositive renal transplant recipient treated with OKT3.

    Patricia Hibberd;Nina Tolkoff-Rubin;A. Cosimi;Robert Schooley

  • Preemptive ganciclovir therapy to prevent cytomegalovirus disease, in cytomegalovirus antibody-positive renal transplant recipients. A randomized controlled trial

    P. L. Hibberd;N. E. Tolkoff-Rubin;D. Conti;F. Stuart

  • Plasma exchange and tacrolimus-mycophenolate rescue for acute humoral rejection in kidney transplantation.

    Manuel Pascual;Susan Saidman;Nina Tolkoff-rubin;Winfred W. Williams

Frequent Co-Authors

Robert H. Rubin
Robert H. Rubin Brigham and Women's Hospital
Cosimi Ab
Cosimi Ab Harvard University
Francis L. Delmonico
Francis L. Delmonico Harvard University
Robert B. Colvin
Robert B. Colvin Harvard University
Paul S. Russell
Paul S. Russell Harvard University
David H. Sachs
David H. Sachs Columbia University
Megan Sykes
Megan Sykes Columbia University
Hugh Auchincloss
Hugh Auchincloss National Institutes of Health
Frederic I. Preffer
Frederic I. Preffer Harvard University
Jay A. Fishman
Jay A. Fishman Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Aspiring medical professionals and those looking to advance their healthcare careers now have a wealth of flexible online education options. For those interested in healthcare administration, enrolling in top online mha programs that are cahme accredited ensures you gain high-quality training with industry-recognized credentials.

If you are a registered nurse aiming to boost your qualifications, there are rn to bsn programs without clinicals available online. These pathways offer increased flexibility and allow you to balance studies with existing work commitments.

For those seeking rapid career progression in nursing, consider enrolling in one of the fastest dnp program options online. These programs are designed to help you achieve a Doctor of Nursing Practice qualification in less time.

Cost is also a key concern for many students. Fortunately, several affordable dnp programs are recognized for blending quality with value, ensuring your educational investment goes further.

With a range of accredited and flexible online degrees, students can pursue specialized career pathways within healthcare while managing personal and professional responsibilities.

Best Scientists Citing Nina Tolkoff-Rubin

Trending Scientists

Recently Published Articles